Network Pharmacology-Based Dissection of the Anti-diabetic Mechanism of Lobelia chinensis
出版年份 2020 全文链接
标题
Network Pharmacology-Based Dissection of the Anti-diabetic Mechanism of Lobelia chinensis
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-03-20
DOI
10.3389/fphar.2020.00347
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The p38/MKP-1 signaling axis in oral cancer: Impact of tumor-associated macrophages
- (2020) Zhenning Li et al. ORAL ONCOLOGY
- Constitutive Activation of β-Catenin in Conventional Dendritic Cells Increases the Insulin Reserve to Ameliorate the Development of Type 2 Diabetes in Mice
- (2019) Claire E. Macdougall et al. DIABETES
- Evidence and Potential Mechanisms of Traditional Chinese Medicine for the Treatment of Type 2 Diabetes: A Systematic Review and Meta‐analysis
- (2019) Jiaxing Tian et al. DIABETES OBESITY & METABOLISM
- Long-term exposure to TNF-α leads human skin fibroblasts to a p38 MAPK- and ROS-mediated premature senescence
- (2018) Eleni Mavrogonatou et al. BIOGERONTOLOGY
- Analysis of mulberry leaf components in the treatment of diabetes using network pharmacology
- (2018) Qi Ge et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Maduramicin-activated protein phosphatase 2A results in extracellular signal-regulated kinase 1/2 inhibition, leading to cytotoxicity in myocardial H9c2 cells
- (2018) Xin Chen et al. TOXICOLOGY LETTERS
- Mulberry Leaf Regulates Differentially Expressed Genes in Diabetic Mice Liver Based on RNA-Seq Analysis
- (2018) Qi Ge et al. Frontiers in Physiology
- A Network Pharmacology Approach to Uncover the Molecular Mechanisms of Herbal Formula Ban-Xia-Xie-Xin-Tang
- (2018) Ming Yang et al. Evidence-based Complementary and Alternative Medicine
- A Biomedical Investigation of the Hepatoprotective Effect of Radix salviae miltiorrhizae and Network Pharmacology-Based Prediction of the Active Compounds and Molecular Targets
- (2017) Ming Hong et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Network pharmacology-based study on the mechanism of action for herbal medicines in Alzheimer treatment
- (2017) Jiansong Fang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Network-based Approaches in Pharmacology
- (2017) Baptiste Boezio et al. Molecular Informatics
- A Network-Based Pharmacology Study of the Herb-Induced Liver Injury Potential of Traditional Hepatoprotective Chinese Herbal Medicines
- (2017) Ming Hong et al. MOLECULES
- Herb pair Danggui-Honghua: mechanisms underlying blood stasis syndrome by system pharmacology approach
- (2017) Shi-Jun Yue et al. Scientific Reports
- Treatment of Diabetes Mellitus Using iPS Cells and Spice Polyphenols
- (2017) Qi Ge et al. Journal of Diabetes Research
- System Pharmacology-Based Dissection of the Synergistic Mechanism of Huangqi and Huanglian for Diabetes Mellitus
- (2017) Shi-Jun Yue et al. Frontiers in Pharmacology
- The effect of Liuwei Dihuang decoction on PI3K/Akt signaling pathway in liver of type 2 diabetes mellitus (T2DM) rats with insulin resistance
- (2016) Bing Dai et al. JOURNAL OF ETHNOPHARMACOLOGY
- Effect of mulberry leaf (Folium Mori) on insulin resistance via IRS-1/PI3K/Glut-4 signalling pathway in type 2 diabetes mellitus rats
- (2016) Shengyu Cai et al. PHARMACEUTICAL BIOLOGY
- C5a Induces the Synthesis of IL-6 and TNF-α in Rat Glomerular Mesangial Cells through MAPK Signaling Pathways
- (2016) Mingde Ji et al. PLoS One
- Evidence-based absorption, distribution, metabolism, excretion (ADME) and its interplay with alternative toxicity methods
- (2016) Katya Tsaioun ALTEX-Alternatives to Animal Experimentation
- Insulin receptor alternative splicing is regulated by insulin signaling and modulates beta cell survival
- (2016) Pushkar Malakar et al. Scientific Reports
- UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis
- (2015) Jong-Seok Moon et al. JOURNAL OF CLINICAL INVESTIGATION
- Aberrant Liver Insulin Receptor Isoform A Expression Normalises with Remission of Type 2 Diabetes after Gastric Bypass Surgery
- (2015) Vinko Besic et al. PLoS One
- Vildagliptin, a DPP-4 inhibitor for the twice-daily treatment of type 2 diabetes mellitus with or without metformin
- (2014) Thomas Forst et al. EXPERT OPINION ON PHARMACOTHERAPY
- Chemical constituents of Lobelia chinensis
- (2014) Shuang Yang et al. FITOTERAPIA
- TCMSP: a database of systems pharmacology for drug discovery from herbal medicines
- (2014) Jinlong Ru et al. Journal of Cheminformatics
- Protein phosphatase 2A: a target for anticancer therapy
- (2013) Danilo Perrotti et al. LANCET ONCOLOGY
- Diabetic Retinopathy
- (2012) David A. Antonetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chemical constituents from Lobelia chinensis and their anti-virus and anti-inflammatory bioactivities
- (2011) Ping-Chung Kuo et al. ARCHIVES OF PHARMACAL RESEARCH
- Unveiling the role of network and systems biology in drug discovery
- (2010) Albert Pujol et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials
- (2008) Avraham Karasik et al. CURRENT MEDICAL RESEARCH AND OPINION
- Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes
- (2008) Katrina MacAulay et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- TNF-mediated inflammatory disease
- (2007) JR Bradley JOURNAL OF PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now